ArticleThe Lancet. Oncology2021

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.

Elizabeth K Bancroft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.